Outcomes of COVID-19-Positive Donor Heart Transplantation in the United States.

Publication/Presentation Date

7-18-2023

Abstract

Background Little is known regarding the impact of donor COVID-19 status on recipient outcomes after heart transplantation. In this study, we characterize outcomes of the first 110 heart transplants from organ donors positive for COVID-19 (COVID-19+) in the United States. Methods and Results Retrospective analysis of the United Network for Organ Sharing database was performed for single-organ adult heart transplants from January 2020 to March 2022. Donor COVID-19+ status was defined as a positive nucleic acid amplification, antigen, or other COVID-19 test within 7 days of transplant. Nearest-neighbor propensity score matching used to adjust for differences between recipients of COVID-19+ and nonpositive donor hearts. Overall, 7251 heart transplants were included in analysis, with 110 using COVID-19+ donor hearts. Recipients of COVID-19+ allografts were younger (54 [interquartile range, 41-61]) versus 57 [46-64] years;

Volume

12

Issue

14

First Page

029178

Last Page

029178

ISSN

2047-9980

Disciplines

Medicine and Health Sciences

PubMedID

37421286

Department(s)

Department of Surgery

Document Type

Article

Link to Full Text

Share

COinS